机构:[1]Department of Nuclear Medicine, Peking University Third Hospital, Beijing, China[2]Department of Ophthalmology, Peking University Third Hospital, Beijing, China[3]Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China[4]Department of Otorhinolaryngology, Peking University Third Hospital, Beijing, China[5]Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China[6]Department of Pathology, Peking Union Medical College Hospital, Beijing, China[7]Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China[8]Ophthalmology and Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院
This work was supported by the National Natural Science
Foundation of China (Grant No. 82201180) and the Key Clinical Projects
of Peking University Third Hospital (Grant No. BYSY2022060).
第一作者机构:[1]Department of Nuclear Medicine, Peking University Third Hospital, Beijing, China
共同第一作者:
通讯作者:
通讯机构:[2]Department of Ophthalmology, Peking University Third Hospital, Beijing, China[3]Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China
推荐引用方式(GB/T 7714):
Li Hui,Wang Yi,Zhou Jichao,et al.Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET/CT: A prospective study[J].European Journal Of Nuclear Medicine And Molecular Imaging.2024,doi:10.1007/s00259-024-07015-y.
APA:
Li Hui,Wang Yi,Zhou Jichao,You Debo,Song Le...&Suo Lingge.(2024).Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET/CT: A prospective study.European Journal Of Nuclear Medicine And Molecular Imaging,,
MLA:
Li Hui,et al."Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET/CT: A prospective study".European Journal Of Nuclear Medicine And Molecular Imaging .(2024)